Array
(
[id] => 6214785
[patent_doc_number] => 20110137026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'Crystalline (6r,7r)-7--3- [(R)-1\'-Tert-Butoxycarbonyl-2-Oxo-[1,3\']Bipyrrolidinyl-(3e)-Ylidenemethyl]-8-Oxo-5-Thia-1-Aza-Bicyclo[4.2.0] Oct-2-Ene-2-Carboxylic Acid Benzhydryl Ester; Its Manufacture and Use'
[patent_app_type] => utility
[patent_app_number] => 12/937607
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 22153
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20110137026.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937607
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937607 | Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(Z)-trityloxyimino]-acetylamino}-3-[(R)-1′-tert-butoxycarbonyl-2-oxo-[1,3′]bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester; its manufacture and use | Apr 13, 2009 | Issued |
Array
(
[id] => 10876356
[patent_doc_number] => 08901141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-02
[patent_title] => 'Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them'
[patent_app_type] => utility
[patent_app_number] => 12/863851
[patent_app_country] => US
[patent_app_date] => 2009-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 235812
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12863851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863851 | Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them | Jan 20, 2009 | Issued |
Array
(
[id] => 10013853
[patent_doc_number] => 09056864
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'Crystalline form of abacavir that is essentially free of solvent'
[patent_app_type] => utility
[patent_app_number] => 12/863708
[patent_app_country] => US
[patent_app_date] => 2009-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4262
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12863708
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863708 | Crystalline form of abacavir that is essentially free of solvent | Jan 20, 2009 | Issued |
Array
(
[id] => 5447121
[patent_doc_number] => 20090048347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic'
[patent_app_type] => utility
[patent_app_number] => 12/218624
[patent_app_country] => US
[patent_app_date] => 2008-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7468
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12218624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/218624 | Topical anesthetic for rapid local anesthesia and method of applying a topical anesthetic | Jul 15, 2008 | Issued |